Enhancing pre-clinical research with simplified intestinal cell line models

被引:2
|
作者
Fey, Christina [1 ]
Truschel, Theresa [2 ]
Nehlsen, Kristina [2 ]
Damigos, Spyridon [3 ]
Horstmann, Julia [4 ]
Stradal, Theresia [4 ]
May, Tobias [2 ]
Metzger, Marco [1 ,3 ]
Zdzieblo, Daniela [1 ,3 ,5 ]
机构
[1] Branch Fraunhofer Inst Silicate Res ISC, Translat Ctr Regenerat Therapies TLZ RT Wurzburg, Rontgenring 12, D-97070 Wurzburg, Germany
[2] InSCREENeX GmbH, Braunschweig, Germany
[3] Univ Hosp Wurzburg, Dept Tissue Engn & Regenerat Med TERM, Wurzburg, Germany
[4] Helmholtz Ctr Infect Res, Braunschweig, Germany
[5] Branch Fraunhofer Inst Silicate Res ISC, Project Ctr Stem Cell Proc Engn PZ SPT, Wurzburg, Germany
关键词
Small intestinal tissue; immortalization; organoids; cell line; Transwell (R) models; SOLUTE CARRIER TRANSPORTERS; IN-VITRO MODEL; EPITHELIAL-CELLS; CULTURE-SYSTEM; DRUG TRANSPORT; STEM-CELLS; IMMORTALIZATION; PERMEABILITY; TELOMERASE; MUCUS;
D O I
10.1177/20417314241228949
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Two-dimensional culture remains widely employed to determine the bioavailability of orally delivered drugs. To gain more knowledge about drug uptake mechanisms and risk assessment for the patient after oral drug admission, intestinal in vitro models demonstrating a closer similarity to the in vivo situation are needed. In particular, Caco-2 cell-based Transwell (R) models show advantages as they are reproducible, cost-efficient, and standardized. However, cellular complexity is impaired and cell function is strongly modified as important transporters in the apical membrane are missing. To overcome these limitations, primary organoid-based human small intestinal tissue models were developed recently but the application of these cultures in pre-clinical research still represents an enormous challenge, as culture setup is complex as well as time- and cost-intensive. To overcome these hurdles, we demonstrate the establishment of primary organoid-derived intestinal cell lines by immortalization. Besides exhibiting cellular diversity of the organoid, these immortalized cell lines enable a standardized and more cost-efficient culture. Further, our cell line-based Transwell (R)-like models display an organ-specific epithelial barrier integrity, ultrastructural features and representative transport functions. Altogether, our novel model systems are cost-efficient with close similarity to the in vivo situation, therefore favoring their use in bioavailability studies in the context of pre-clinical screenings.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] In vitro models: a new era in pre-clinical researchIn vitro models: a new era in pre-clinical research
    Oliveira, J. Miguel
    TISSUE ENGINEERING PART A, 2022, 28 : 136 - 136
  • [2] MICROSURGICAL MODELS AS FUNDAMENTALS OF PRE-CLINICAL TRANSPLANTATION RESEARCH
    THIEDE, A
    ENGEMANN, R
    DELTZ, E
    TIMMERMANN, W
    SCHANG, T
    ULRICHS, K
    HAMELMANN, H
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1983, 361 : 924 - 924
  • [3] ENHANCING THE VALUE OF PRE-CLINICAL STUDIES
    Macleod, M.
    OSTEOARTHRITIS AND CARTILAGE, 2017, 25 : S3 - S3
  • [4] Pre-clinical cancer models
    Jackstadt, R. F.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S115 - S115
  • [5] Pre-clinical models of MDS
    Nowak, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 50 - 50
  • [6] Improving Microliter Injections in Pre-clinical Models for Ophthalmic Research
    Schaefer, Andrew
    Castagna, Lou
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [7] Miniaturized pre-clinical cancer models as research and diagnostic tools
    Hakanson, Maria
    Cukierman, Edna
    Charnley, Mirren
    ADVANCED DRUG DELIVERY REVIEWS, 2014, 69 : 52 - 66
  • [8] PRE-CLINICAL EVALUATION OF COGNITION ENHANCING DRUGS
    SCHINDLER, U
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1989, 13 : S99 - S115
  • [9] Pre-clinical animal models of osteoarthritis
    Chen, Qian
    Wei, Lei
    Yang, Xu
    BONE, 2010, 47 : S350 - S351
  • [10] Editorial: Pre-clinical Models of PTSD
    Perrine, Shane A.
    Liberzon, Israel
    FRONTIERS IN BEHAVIORAL NEUROSCIENCE, 2019, 13